Rothschild Capital Partners’s St Jude Medical STJ Stock Holding History
Bought
Maintained
Sold
Other funds holding STJ
FCM
BIT
BFA
Rothschild Capital Partners's STJ Position: Q4 2016 in Review
Rothschild Capital Partners sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 63,829 shares — an estimated $5.09M sold.
Rothschild Capital Partners first reported a position in STJ in Q2 2013 and held it in 14 quarters. The position peaked at $7.02M in Q2 2014. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.
- Rothschild Capital Partners reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
- Rothschild Capital Partners sold 63,829 St Jude Medical shares in Q4 2016, an estimated $5.09M.
- Rothschild Capital Partners first reported a position in St Jude Medical in Q2 2013 and held it in 14 quarters.
- Rothschild Capital Partners's St Jude Medical position peaked at $7.02M in Q2 2014.
- 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.
Based on Rothschild Capital Partners's 13F filing for Q4 2016, filed 30 Jan 2017.